← All trials
NCT04171388
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2019
- Primary completion
- May 28, 2021
- Completion date
- Nov 30, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 5280
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Harvard UniversityLead sponsor
- JhpiegoCollaborator
- Johns Hopkins UniversityCollaborator
- Harvard UniversityCollaborator
- Harvard UniversityReponsible party - principal investigator
- Amhara Public Health InstituteCollaborator
- Addis Continental Institute of Public HealthCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.